You may be trying to access this site from a secured browser on the server. Please enable scripts and reload this page.
American Association for Clinical Chemistry
Better health through laboratory medicine
Home
|
Customer Service
|
Site Map
|
Cart
|
Login
About AACC
Members
Events
Government & Public Affairs
Resource Centers
Professional Development
Publications
AACC Store
>
Members
>
NACB - The AACC Academy
>
NACB Blog
Recent Posts
Should We Still be Performing Fetal Fibronectin Testing in the Clinical Lab?
What is the diagnosis?
Newborn Screening for Severe Combined Immunodeficiency (SCID): Should it be performed?
Are reference change values more useful than population-based reference intervals?
Categories
Cancer and Tumor Markers
Case Study
Clinical Translational Science/Proteomics
CVD/Markers/Risk Factors
Diabetes/Endocrinology
Government Affairs/Patient Safety
Immunology/Infectious Disease
Instrumentation/Technology
Management/Medical Informatics
Molecular Pathology and Genetics
New/Other Disease Markers
Nutrition
POC Testing
Renal/GI/Hepatic
Special Populations
TDM/Toxicology
Archives
Year
: 2013
June 2013
May 2013
April 2013
March 2013
February 2013
January 2013
Year
: 2012
December 2012
November 2012
October 2012
September 2012
August 2012
July 2012
June 2012
May 2012
April 2012
March 2012
February 2012
January 2012
Year
: 2011
December 2011
November 2011
October 2011
September 2011
August 2011
July 2011
June 2011
May 2011
April 2011
March 2011
February 2011
January 2011
RSS Feed
NACB Blog
Is it Time to Remove the Stigma of LDT from Body Fluid Chemistry Assays?
7/26/2011 7:50 AM |
Comments (1)
Recommend (843)
By
James C. Ritchie, PhD
By now we’ve all probably heard of LDTs (laboratory developed tests) and the FDA’s decision to begin exercising regulatory authority over them in the near future. Unless you work in a large reference lab, a molecular lab, or in an esoteric subsection of the lab you probably thought this had nothin...(
Read More
)
Posted at 7/26/2011 7:50 AM | Tags:
Government Affairs/Patient Safety
Don’t Ask, Don’t Tell: RUO and IUO
7/19/2011 8:16 AM |
Comments (3)
Recommend (840)
By
Patti Jones, PhD, FACB, and Jason Park, MD
Perhaps it has come to this. On June 1, 2011 a new guidance document draft was released for comment by the US Department of Health and Human Services, the FDA, the Center for Devices and Radiological Health, the Office of In Vitro Diagnostic Device Evaluation and Safety and the Center for Biologica...(
Read More
)
Posted at 7/19/2011 8:16 AM | Tags:
Government Affairs/Patient Safety
Serological Markers of Type 1 Diabetes
7/12/2011 8:05 AM |
Comments (0)
Recommend (842)
By
William Winter, MD
Type 1 diabetes mellitus (T1DM) is an autoimmune disease that results from the cell-mediated destruction of islet beta cells. Approximately 12,000 to 15,000 children and adults annually develop T1DM. Over a period of 50 years, this amounts to 600,000 to 750,000 affected individuals. As well, these ...(
Read More
)
Posted at 7/12/2011 8:05 AM | Tags:
Diabetes/Endocrinology
Severe Hypocalcemia Without Symptoms: Another Lab Error?
7/5/2011 8:32 AM |
Comments (13)
Recommend (1,056)
By
William Winter, MD
A 58-year-old man underwent MRI total body imaging. Later that day, a chemistry profile was ordered. The total calcium was measured at 4 mg/dL (reference interval: 8.5-10.5 mg/dL) and the albumin was 4 g/dL (reference interval: 3.5-5.0 g/dL). The patient was examined and lacked any clinical evidenc...(
Read More
)
Posted at 7/5/2011 8:32 AM | Tags:
Case Study
(Hidden) Admin Links
About AACC
|
Members
|
Government & Public Affairs
|
Resource Centers
|
Professional Development
|
Publications
Home
|
Customer Service
|
Site Map
|
AACC Store
|
Login
Contact Us
|
Privacy Policy and Legal Disclaimer
|
Join AACC
©2013 American Association for Clinical Chemistry
1850 K Street, NW Suite 625
Washington, DC 20006
Phone: (800) 892-1400 | Fax: (202) 887-5093